Take Action: SGO Needs Your Help on These Important Requests
Download the SGO Grassroots Advocacy Toolkit
TAKE ACTION – Tell Congress: Stop the OMB Proposed Rule on Federal Grants
On May 29, the Office of Management and Budget (OMB) published a proposed rule that would make significant changes to the way the federal government selects, manages, and terminates government-funded awards, such as grants, cooperative agreements, and contracts. Proposed changes expand OMB’s authority over federal grant design and oversight, impose new requirements on grantee selection and funding decisions to be aligned with the Administration’s priorities, allow agencies to cancel grant awards at any time for any reason, and significantly limit the types of costs that are allowable under federal awards.
If finalized, the rule would have broad implications for organizations that receive federal funding, such as universities, research institutions, hospitals, nonprofits, state and local governments, impacting gynecologic oncology research, care, and workforce programs funded by federal agencies, such as the Department of Human and Health Services (HHS), the Department of Veterans Affairs (VA), and the Department of Defense (DoD).
Please act now to tell your Member of Congress about the OMB’s proposed rule’s harmful effects on federally funded activities, and the impact it would have on your district and state.
Urge Congress to take action to ensure OMB withdraws this proposed rule!
TAKE ACTION – Ask Your Senators to Support an Endometrial Cancer Line Item
On June 24, the House Appropriations Committee advanced the House Fiscal Year (FY) 2027 Defense Appropriations bill. In a major advocacy milestone, the House FY 2027 Defense Appropriations report includes a new $10 million line item for an Endometrial Cancer Research Program within the Department of Defense (DoD) Congressionally Directed Medical Research Program (CDMRP).
The National Defense Authorization Act for FY 2026 authorized the creation of an Endometrial Cancer Research Program within CDMRP funded at $10 million, and the House report marks the first appropriations cycle in which funding for the program was included in an appropriations bill.
But the work is not done. Attention now turns to the Senate appropriations process, and SGO needs your help. We are asking Senate offices to include this same $10 million investment in its FY 2027 Defense appropriations bill to support and implement the program.
Please act now and urge your Senators to support funding for this critical research!
Tell Congress to Reform Medicare’s Physician Payment System!
Medicare relies on physicians to provide care for millions of seniors, yet reimbursement for physician services have failed to keep pace with the rising costs and complexity of delivering care. This growing gap threatens patient access, particularly in gynecologic oncology, where workforce shortages already exist and access to specialized care is critical.
Congress is actively considering legislation to modernize the Medicare physician payment system, including a bipartisan effort by the House GOP and Democratic Doctors Caucuses, to reform the ways in which physicians are reimbursed through Medicare. SGO is advocating for reforms that help ensure Medicare reimbursements better reflect the realities of providing care and support continued access to high-quality gynecologic oncology services.
Tell your representatives about the three key reforms that should be in any Medicare physician payment reform legislation so that we can stabilize physician reimbursement and preserve patient access to the specialized care SGO members provide.
ACT NOW TO REAUTHORIZE JOHANNA’S LAW
Johanna’s Law has been a cornerstone of federal efforts to improve education and awareness of gynecologic cancers for nearly two decades. Because there are no routine screening tests for most gynecologic cancers, increasing awareness of symptoms and risk factors remains one of the most effective tools we have to promote earlier detection and improve patient outcomes. Through the Centers for Disease Control and Prevention (CDC), this law supports initiatives like the Inside Knowledge: Get the Facts About Gynecologic Cancer campaign, which have helped educate both patients and providers and address persistent gaps in understanding across cancer types.
Without congressional action, these important education and outreach efforts could be disrupted. Along with increased funding, reauthorization will allow the CDC to continue and expand this work, particularly in underserved communities where disparities in gynecologic cancer outcomes remain significant.
SGO is urging Congress to reauthorize Johanna’s Law for three years from FY 2027 through FY 2029 and appropriate $15 million in funding for FY 2027. Please send a message to your members of Congress to advocate for the program’s reauthorization and the importance of sustained federal investment in gynecologic cancer education and awareness.
Support the Seniors’ Timely Access to Care Act of 2025
Prior authorization requirements in Medicare Advantage plans are increasingly delaying access to critical services for patients with gynecologic cancers. While intended to control costs and ensure appropriate care, these processes often create unnecessary barriers—particularly in oncology, where timely diagnosis and treatment are essential. Delays in approving imaging, procedures, and other services can postpone care, increase patient anxiety, and in some cases contribute to disease progression.
At the same time, prior authorization places a significant administrative burden on oncology practices. Physicians and their staff spend hours navigating complex and inconsistent requirements, diverting time and resources away from direct patient care. This burden is especially acute in specialty care settings like gynecologic oncology, where treatment is often complex and time sensitive.
The Improving Seniors’ Timely Access to Care Act of 2025 (H.R. 1816/S. 3514) would streamline prior authorization in Medicare Advantage by establishing electronic processes, improving transparency, and requiring more timely decisions. While it does not address prior authorization for prescription drugs, it represents an important step toward reducing delays and improving access to care for cancer patients.
SGO urges members to act and ask their members of Congress to co-sponsor the bill if they haven’t already and support its adoption this year!
